Literature DB >> 28577499

Leukocyte trafficking in tumor microenvironment.

Annalisa Del Prete1, Tiziana Schioppa2, Laura Tiberio2, Helena Stabile3, Silvano Sozzani4.   

Abstract

The tumor microenvironment consists of both malignant and non-malignant cells and a plethora of soluble mediators. Different types of tumors have specific tumor microenvironments characterized by distinct chemokines and chemotactic factors that influence leukocyte recruitment. The immune cell infiltrate continuously interacts with stroma cells and influence tumor growth. Emerging evidence suggests that the regulation of the composition and the metabolic state of tumor-associated leukocytes may represent a new promising intervention strategy. Here we summarize the current knowledge on the role of tumor-associated immune cells in tumor growth and dissemination, with a specific focus on the nature of the chemotactic factors responsible for their accumulation and activation in tumors.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2017        PMID: 28577499     DOI: 10.1016/j.coph.2017.05.004

Source DB:  PubMed          Journal:  Curr Opin Pharmacol        ISSN: 1471-4892            Impact factor:   5.547


  27 in total

1.  The Atypical Receptor CCRL2 Is Essential for Lung Cancer Immune Surveillance.

Authors:  Annalisa Del Prete; Francesca Sozio; Tiziana Schioppa; Andrea Ponzetta; William Vermi; Stefano Calza; Mattia Bugatti; Valentina Salvi; Giovanni Bernardini; Federica Benvenuti; Annunciata Vecchi; Barbara Bottazzi; Alberto Mantovani; Silvano Sozzani
Journal:  Cancer Immunol Res       Date:  2019-09-04       Impact factor: 11.151

2.  Structural Biology of the Tumor Microenvironment.

Authors:  Joseph W Freeman
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

3.  A Systematic Pan-Cancer Analysis of YY1 Aberrations and their Relationship with Clinical Outcome, Tumor Microenvironment, and Therapeutic Targets.

Authors:  Xinghao Fu; Feihong Ji; Qi He; Xinguang Qiu
Journal:  J Immunol Res       Date:  2022-06-24       Impact factor: 4.493

4.  Tumor Microenvironment Characterization in Breast Cancer and an Immune Cell Infiltration Score Development, Validation, and Application.

Authors:  Lang Li
Journal:  Front Oncol       Date:  2022-06-27       Impact factor: 5.738

Review 5.  Chemokine Heterocomplexes and Cancer: A Novel Chapter to Be Written in Tumor Immunity.

Authors:  Gianluca D'Agostino; Valentina Cecchinato; Mariagrazia Uguccioni
Journal:  Front Immunol       Date:  2018-09-25       Impact factor: 7.561

6.  Distinct Spatio-Temporal Dynamics of Tumor-Associated Neutrophils in Small Tumor Lesions.

Authors:  Simon Sody; Mohib Uddin; Anika Grüneboom; André Görgens; Bernd Giebel; Matthias Gunzer; Sven Brandau
Journal:  Front Immunol       Date:  2019-06-25       Impact factor: 7.561

Review 7.  Inflammation-Driven Breast Tumor Cell Plasticity: Stemness/EMT, Therapy Resistance and Dormancy.

Authors:  Tamir Baram; Linor Rubinstein-Achiasaf; Hagar Ben-Yaakov; Adit Ben-Baruch
Journal:  Front Oncol       Date:  2021-01-26       Impact factor: 6.244

Review 8.  The Role of V-Domain Ig Suppressor of T Cell Activation (VISTA) in Cancer Therapy: Lessons Learned and the Road Ahead.

Authors:  Negar Hosseinkhani; Afshin Derakhshani; Mahdi Abdoli Shadbad; Antonella Argentiero; Vito Racanelli; Tohid Kazemi; Ahad Mokhtarzadeh; Oronzo Brunetti; Nicola Silvestris; Behzad Baradaran
Journal:  Front Immunol       Date:  2021-05-19       Impact factor: 7.561

9.  Continuous Inflammatory Stimulation Leads via Metabolic Plasticity to a Prometastatic Phenotype in Triple-Negative Breast Cancer Cells.

Authors:  Dina Morein; Linor Rubinstein-Achiasaf; Hadar Brayer; Orly Dorot; Edward Pichinuk; Hagar Ben-Yaakov; Tsipi Meshel; Metsada Pasmanik-Chor; Adit Ben-Baruch
Journal:  Cells       Date:  2021-05-31       Impact factor: 6.600

Review 10.  Tumor Microenvironment.

Authors:  Borros Arneth
Journal:  Medicina (Kaunas)       Date:  2019-12-30       Impact factor: 2.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.